Your browser doesn't support javascript.
loading
Agonist-selective activation of individual G-proteins by muscarinic receptors.
Nelic, Dominik; Chetverikov, Nikolai; Hochmalová, Martina; Diaz, Christina; Dolezal, Vladimír; Boulos, John; Jakubík, Jan; Martemyanov, Kirill; Janousková-Randáková, Alena.
Afiliação
  • Nelic D; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
  • Chetverikov N; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
  • Hochmalová M; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
  • Diaz C; Department of Physical Sciences, Barry University, Miami Shores, Miami, FL, USA.
  • Dolezal V; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
  • Boulos J; Department of Physical Sciences, Barry University, Miami Shores, Miami, FL, USA.
  • Jakubík J; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
  • Martemyanov K; Department of Neuroscience, UF Scripps Biomedical Research, University of Florida, Jupiter, FL, 33458, USA. kmartemyanov@ufl.edu.
  • Janousková-Randáková A; Department of Neurochemistry, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. alena.janouskova@fgu.cas.cz.
Sci Rep ; 14(1): 9652, 2024 04 26.
Article em En | MEDLINE | ID: mdl-38671143
ABSTRACT
Selective activation of individual subtypes of muscarinic receptors is a promising way to safely alleviate a wide range of pathological conditions in the central nervous system and the periphery as well. The flexible G-protein interface of muscarinic receptors allows them to interact with several G-proteins with various efficacy, potency, and kinetics. Agonists biased to the particular G-protein mediated pathway may result in selectivity among muscarinic subtypes and, due to the non-uniform expression of individual G-protein alpha subunits, possibly achieve tissue specificity. Here, we demonstrate that novel tetrahydropyridine-based agonists exert specific signalling profiles in coupling with individual G-protein α subunits. These signalling profiles profoundly differ from the reference agonist carbachol. Moreover, coupling with individual Gα induced by these novel agonists varies among subtypes of muscarinic receptors which may lead to subtype selectivity. Thus, the novel tetrahydropyridine-based agonist can contribute to the elucidation of the mechanism of pathway-specific activation of muscarinic receptors and serve as a starting point for the development of desired selective muscarinic agonists.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Muscarínicos / Agonistas Muscarínicos Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Muscarínicos / Agonistas Muscarínicos Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article